HH
RCUS icon

Hilltop Holdings’s Arcus Biosciences RCUS Stock Holding History

Hilltop Holdings’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-11,075
Closed -$136K – 462
2018
Q2 		$136K Buy
+11,075
New +$174K 0.03% 399

Other funds holding RCUS

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hilltop Holdings's RCUS Position: Q3 2018 in Review

Hilltop Holdings sold out of Arcus Biosciences (RCUS) in Q3 2018, closing a stake of 11,075 shares — an estimated $136K sold.

Hilltop Holdings first reported a position in RCUS in Q2 2018 and held it in 1 quarter. The position peaked at $136K in Q2 2018. 57 funds tracked by Wall St. Rank hold RCUS as of Q3 2018.

  • Hilltop Holdings reported no remaining Arcus Biosciences position as of Q3 2018 after selling out during the quarter.
  • Hilltop Holdings sold 11,075 Arcus Biosciences shares in Q3 2018, an estimated $136K.
  • Hilltop Holdings first reported a position in Arcus Biosciences in Q2 2018 and held it in 1 quarter.
  • Hilltop Holdings's Arcus Biosciences position peaked at $136K in Q2 2018.
  • 57 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2018.

Based on Hilltop Holdings's 13F filing for Q3 2018, filed 14 Nov 2018.